Publication:
Surgical Technology International XVII - Cardiovascular Surgery
Article title:
Strategies to Reduce Blood Loss During Posterior Spinal Fusion for Neuromuscular Scoliosis: A Review of Current Techniques and Experience with a Unique Bipolar Electrocautery Device
Order Article:

Reprint Copies:  500 - $1,960.00

1000 - $3,720.00

By e-mail: PDF Format - $69.00

 

Author(s)

Amer F. Samdani, M.D.
Staff Surgeon, Shriners Hospitals for Children, Philadelphia, Pennsylvania, USA

 

Andrew Torre-Healy, B.S.
Student, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA

 

JahanGir Asghar, M.D.
Spine Fellow, Shriners Hospitals for Children, Philadelphia, Pennsylvania, USA


Andrew M. Herlich, M.D.
Anesthesiologist, Temple University Hospital, Philadelphia, Pennsylvania, USA

 

Randal R. Betz, M.D.
Chief of Staff, Shriners Hospitals for Children, Philadelphia, Pennsylvania, USA

Abstract
In this chapter, we review current techniques employed to decrease blood loss and describe the effective use of a unique bipolar electrocautery device in a patient with neuromuscular scoliosis undergoing posterior spinal fusion (PSF). The reduction of blood loss and subsequent elimination of allogeneic blood transfusion is a desired outcome in all surgeries and is a major concern during PSF. In the child or adolescent with neuromuscular scoliosis, this becomes a greater concern due to a variety of factors such as the inability of the musculature to compress blood vessels, extensive surgical exposure, and the duration of the operation. A multitude of pharmacological, anesthetic, and surgical techniques-including preoperative autologous blood donation and human recombinant erythropoietin, intraoperative blood salvage techniques, and topical and systemic hemostatic agents-are employed to reduce the need for transfusion. Many of these techniques carry their own risks and, thus far, a systematic approach has not been established to decrease the need for transfusion. In the continued pursuit of reducing intraoperative blood loss, other surgical techniques must be developed.

 

 

Product featured in the Article:

 

Aquamantys™

CoStasis™

FloSeal™

Surgicel™

Surgifoam™